Apollomics, Inc. (NASDAQ:APLMW) Sees Large Increase in Short Interest

Apollomics, Inc. (NASDAQ:APLMW) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totaling 2,500 shares, an increase of 56.3% from the August 31st total of 1,600 shares. Based on an average daily trading volume, of 202,300 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 202,300 shares, the days-to-cover ratio is currently 0.0 days.

Apollomics Stock Performance

Apollomics stock opened at $0.02 on Thursday. The firm’s fifty day moving average price is $0.02 and its 200-day moving average price is $0.02. Apollomics has a fifty-two week low of $0.00 and a fifty-two week high of $0.05.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.